Tag: acute pulmonary embolism
Jupiter Endovascular announce US FDA approval for SPIRARE II trial
Jupiter Endovascular has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application for the SPIRARE II US pivotal study. The pivotal trial...
Novel thrombectomy system demonstrates positive safety and feasibility results in treating...
Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The...
Catheter-directed mechanical thrombectomy system demonstrates safety and effectiveness in patients with...
Results from Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AX) finds significant improvement in right ventricle function and minimal major adverse events.
New...
